Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Primary Lateral Sclerosis

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Primary Lateral Sclerosis

Kyle Kaneko et al.
Free Books & Documents

Excerpt

Primary lateral sclerosis (PLS) is a selective upper motor neuron disorder characterized by insidious onset of symptoms in the absence of lower motor neuron involvement. This condition is a diagnosis of exclusion. Therefore, other causes of upper motor neuron dysfunction, including hereditary spastic paraplegia, must be ruled out. The clinical course of PLS is typically more prolonged and benign than that of amyotrophic lateral sclerosis (ALS). PLS classically involves the lower limbs in a symmetric distribution, although heterogeneity exists with some patients presenting with bulbar onset of symptoms.

Clinical symptoms include stiffness, bulbar symptoms (eg, difficulty speaking and swallowing), labile affect (ie, pseudobulbar affect), mild weakness, and balance and coordination difficulties. PLS is diagnosed after a detailed clinical history, physical exam, and diagnostic testing have excluded other causes. Electromyography (EMG) is often normal but can aid in differentiating PLS from ALS when lower motor neuron dysfunction is observed. Brain magnetic resonance imaging (MRI) may be normal but can show changes in the precentral gyrus or corticospinal tracts, although these findings are not specific to PLS. No cure or disease-modifying treatment has been established for PLS, and treatment is supportive with the primary goal of improving functional mobility.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Kyle Kaneko declares no relevant financial relationships with ineligible companies.

Disclosure: Justin Hoskin declares no relevant financial relationships with ineligible companies.

Disclosure: Brendan Hodis declares no relevant financial relationships with ineligible companies.

References

    1. Statland JM, Barohn RJ, Dimachkie MM, Floeter MK, Mitsumoto H. Primary Lateral Sclerosis. Neurol Clin. 2015 Nov;33(4):749-60. - PMC - PubMed
    1. Vacchiano V, Bonan L, Liguori R, Rizzo G. Primary Lateral Sclerosis: An Overview. J Clin Med. 2024 Jan 19;13(2) - PMC - PubMed
    1. Bede P, Pradat PF, Lope J, Vourc'h P, Blasco H, Corcia P. Primary Lateral Sclerosis: Clinical, radiological and molecular features. Rev Neurol (Paris) 2022 Mar;178(3):196-205. - PubMed
    1. Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, Ravits J, Silani V, Simmons Z, Statland J, van den Berg LH, Delegates of the 2nd International PLS Conference. Mitsumoto H. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):373-377. - PMC - PubMed
    1. Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve. 2007 Mar;35(3):291-302. - PubMed

Publication types

LinkOut - more resources